Back to top

Momentum

Spectrum Pharmaceuticals, Inc. (SPPI - Snapshot Report) saw huge gains in October, jumping more than 50% after posting a huge Q2 earnings surprise of 222%. With estimates on the rise and a high industry rank, this Zacks #1 Rank stock is a biotech with plenty of momentum.

Company Description

Spectrum Pharmaceuticals, Inc. is a commercial stage biotechnology company that focuses on oncology and hematology. The company was founded in 1987 and has a market cap of $633 million.

SPPI got a big lift from the bullish market in October, but shares also gained traction from awesome Q3 results late in the month that came in well ahead of expectations.

Third-Quarter Results

Revenue for the period was up 205% from last year to $51 million. Earnings also came in strong at 29 cents, 222% ahead of the Zacks Consensus Estimate, where Spectrum has one match and three big beats in the last four quarters.

The good quarter was driven by incredible gains in FUSILEV, a chemotherapy agent used in the treatment of colorectal cancer, where sales jumped to $41 million from $6 million last year.

Financial Profile

Spectrum has used its earnings momentum to strengthen its financial profile, with cash and short-term investments up $64 million to $149 million against no long-term debt.

Estimates

We saw some very bullish movement in estimates off the good quarter, with the current year up 53% to $1.04.

Valuation

But in spite of the gains, the valuation picture still looks solid, with SPPI's forward P/E of 11X a discount to its industry average of 15X.

12-Month Chart

On the chart, shares rallied hard in October to hit a new all-time high. Take a look below.

Michael Vodicka is the Momentum Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Whisper Trader Service.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
RPC INC RES 24.91 +8.35%
LITHIA MOTO… LAD 94.59 +4.60%
DELTA AIR L… DAL 39.15 +3.90%
FLAMEL TECH… FLML 14.51 +3.50%
SOUTHWEST A… LUV 28.87 +2.92%